Riskpilot← Back to searchSign inGet full accessLipusplus AB
ABActiveOrg 5560943333Strindbergsgatan 56Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19640 employees
Revenue 2024
SEK 2,2M
+1060% vs 2023
EBITDA margin
-121.0%
+11% vs 2023
Equity ratio
-158.9%
Financial strength
Net profit 2024
SEK -26M
-1167% vs 2023
| Revenue | SEK 2,2M | +1060% |
| EBITDA | SEK -2,7M | +11% |
| Net profit | SEK -26M | -1167% |
| Total assets | SEK 4,6M | -80% |
| Equity | SEK -7,3M | -139% |
| Employees | 0 | — |
Legal name
Lipusplus AB
Org number
5560943333
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2 oktober 1964
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva handel och tillverkning av medicinskt ultraljudssystem, import och export av sådant samt därmed förenlig verksamhet.
Address
Strindbergsgatan 56
Phone
+4647047822
Email
tarapita65@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 192 | 2 227 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −365 | −12 | — | — | — | −6 | 6 | −1 | −3 015 | −2 694 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −4 | −1 497 |
| EBIT | −365 | −12 | 0 | 0 | 0 | −6 | 6 | −1 | −3 019 | −4 191 |
| Net financials | 1 | 176 | — | — | — | — | — | — | 968 | −42 798 |
| Profit before tax | −364 | 164 | 0 | 0 | 0 | −6 | 6 | −1 | −2 051 | −25 988 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −364 | 164 | 0 | 0 | 0 | −6 | 6 | −1 | −2 051 | −25 988 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 55 | 4 | 4 | 4 | 2 | 2 | 12 | 11 | 22 481 | 4 589 |
| Equity | −416 | −252 | −252 | −252 | −252 | −259 | −252 | −253 | 18 696 | −7 292 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 260 | 260 | 10 | 5 010 |
| Short-term debt | 471 | 256 | 256 | 256 | 255 | 261 | 5 | 5 | 3 775 | 6 871 |
| Total debt | 471 | 256 | 256 | 256 | 255 | 261 | 265 | 265 | 3 785 | 11 881 |
EBITDA margin
-121.0%
This company
15.8%
Market median
-866% vs market
20152024
Equity ratio
-158.9%
This company
38.2%
Market median
-516% vs market
20152024
Return on equity
-2598800000.0%
This company
18.4%
Market median
-14123913143% vs market
20152024
Net profit margin
-1167.0%
This company
8.1%
Market median
-14507% vs market
20152024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20152024
Debt / equity
1.63×
This company
0.62×
Market median
-163% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Deputy Board Member | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
J & k Adductorgruppen Aktiebolag | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lipusplus AB 
LipusPlus Horse ABBoard members of Lipusplus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Gustaf Anders Andersson | Audit | 0 companies |
| Benita Eva Terese Jonsson | Deputy Board Member | 0 companies |
| Henrik Gustaf Zethelius Forsström | Board of Directors | 0 companies |
| Leif Olof Rickardsson | Deputy Board Member | 0 companies |
| Ali Arabyarmohammadi | Board of Directors | 0 companies |
| Staffan Petter Forsström | Deputy Board Member | 0 companies |
| Peder Wilhelm Rotkirch | Deputy Board Member | 0 companies |
| Anders Mattias Eklund | Board of Directors | 0 companies |
| Kurth Stephan Jörgne | Deputy Board Member | 0 companies |